Loading Rate of Exogenous and Autoantigenic Determinants on Major Histocompatibility Complex Class II Mediates Resistance to Multiple Sclerosis


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Genetic analysis of thousands of patients with multiple sclerosis (MS) and healthy Russian donors showed that the carriage of groups of HLA-DRB1*15 and HLA-DRB1*03 alleles is associated with the risk of MS, whereas the carriage of groups of HLA-DRB1*01 and HLA-DRB1*11 alleles is protective. Recombinant HLA-DRB1*01:01 with a high affinity can recognize the fragments of myelin basic protein (MBP), one of the autoantigens in MS. However, the comparison of the kinetic parameters of the load of MBP and viral HA peptides on HLA-DRB1*01:01, which is catalyzed by HLA-DM, showed a significantly lower rate of exchange of CLIP for MBP peptides. We assume that the observed protective properties of the group of HLA-DRB1*01 alleles may be directly associated with the ability of HLA-DRB1*01:01 to kinetically distinguish peptides of exogenous and endogenous nature.

About the authors

A. E. Mamedov

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Author for correspondence.
Email: bioaz12@gmail.com
Russian Federation, Moscow, 117997

M. Yu. Zakharova

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences; Pirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation

Email: vera.knorre@gmail.com
Russian Federation, Moscow, 117997; Moscow, 117997

O. O. Favorova

Pirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation

Email: vera.knorre@gmail.com
Russian Federation, Moscow, 117997

O. G. Kulakova

Pirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation

Email: vera.knorre@gmail.com
Russian Federation, Moscow, 117997

A. N. Boyko

Pirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation

Email: vera.knorre@gmail.com
Russian Federation, Moscow, 117997

V. D. Knorre

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Author for correspondence.
Email: vera.knorre@gmail.com
Russian Federation, Moscow, 117997

N. A. Vorobieva

Institute of Gene Biology, Russian Academy of Sciences

Email: vera.knorre@gmail.com
Russian Federation, Moscow, 119334

E. N. Khurs

Engelhardt Institute of Molecular Biology, Russian Academy of Sciences

Email: vera.knorre@gmail.com
Russian Federation, Moscow, 119991

I. S. Kiselev

Pirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation

Email: vera.knorre@gmail.com
Russian Federation, Moscow, 117997

N. M. Baulina

Pirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation

Email: vera.knorre@gmail.com
Russian Federation, Moscow, 117997

A. G. Gabibov

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences; Biological Faculty, Moscow State University

Email: vera.knorre@gmail.com
Russian Federation, Moscow, 117997; Moscow, 119234

A. A. Belogurov

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences; Biological Faculty, Moscow State University

Email: vera.knorre@gmail.com
Russian Federation, Moscow, 117997; Moscow, 119234

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2019 Pleiades Publishing, Inc.